Page last updated: 2024-11-11

4-(4-diethylaminostyryl)-n-methylpyridinium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-(4-diethylaminostyryl)-N-methylpyridinium: fluorescent probe; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

4-(4-diethylaminostyryl)-1-methylpyridinium iodide : An organic iodide salt consisting of pyridinium iodide having a methyl substituent at the 1-position and a 4-diethylaminostyryl substituent at the 4-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5706737
CHEBI ID52771
SCHEMBL ID592722
MeSH IDM0148368

Synonyms (27)

Synonym
4-(4-diethylaminostyryl)-n-methylpyridinium iodide
105802-46-8
4-(4-diethylaminostyryl)-1-methylpyridinium iodide, >=97%
4-(4-diethylaminostyryl)-1-methylpyridinium iodide
4-{(e)-2-[4-(diethylamino)phenyl]ethenyl}-1-methylpyridinium iodide
CHEBI:52771
AKOS000814257
A801320
n,n-diethyl-4-[(e)-2-(1-methylpyridin-1-ium-4-yl)vinyl]aniline iodide
pyridinium, 4-(2-(4-(diethylamino)phenyl)ethenyl)-1-methyl-, iodide
4-di-2-asp
4-(4-diethylaminostyryl)-n-methylpyridinium
SCHEMBL592722
J-100092
d289; 4-di-2-asp
mfcd00031908
pyridinium,4-[2-[4-(diethylamino)phenyl]ethenyl]-1-methyl-,iodide(1:1)
n,n-diethyl-4-[(e)-2-(1-methylpyridin-1-ium-4-yl)ethenyl]aniline;iodide
Q27123592
(e)-4-(4-(diethylamino)styryl)-1-methylpyridinium iodide
DTXSID00909746
n,n-diethyl-4-[2-(1-methylpyridin-4(1h)-ylidene)ethylidene]cyclohexa-2,5-dien-1-iminium iodide
4-(4-diethylaminostyryl)-1-methylpyridiniumiodide
2-di-2-asp [2-(4-diethylaminostyryl)-1-methylpyridinium iodide]
HY-D0060
CS-0009975
4-(4-(diethylamino)styryl)-1-methylpyridin-1-ium iodide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
fluorochromeA fluorescent dye used to stain biological specimens.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
organic iodide salt
pyridinium salt
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (35)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (8.57)18.7374
1990's17 (48.57)18.2507
2000's11 (31.43)29.6817
2010's4 (11.43)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.35

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.35 (24.57)
Research Supply Index3.61 (2.92)
Research Growth Index4.96 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.35)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other36 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]